<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03731416</url>
  </required_header>
  <id_info>
    <org_study_id>Guided bone regeneration</org_study_id>
    <nct_id>NCT03731416</nct_id>
  </id_info>
  <brief_title>Guided Bone Regeneration in Atrophic Anterior Maxillary Ridges</brief_title>
  <official_title>Ridge Augmentation in Atrophic Anterior Maxillary Ridges With Native Collagen Membrane and Anorganic Bovine Bone Derived Mineral With and Without Particulated Autogenous Bone Chips</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aiming to evaluate clinically, radiographically ,and histologically GBR using&#xD;
      collagen membrane in combination with a mixture of ABBM and autogenous particulated bone&#xD;
      compared to collagen membrane with ABBM in atrophied anterior maxilla.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Guided bone regeneration (GBR) has been proposed as a possible alternative for patients with&#xD;
      severe horizontal bone atrophy, to overcome the drawback of bone blocks techniques.6,8 To&#xD;
      protect and prevent the invasion of the clot by nonosteogenic cells, maintaining an adequate&#xD;
      biological space for the regeneration of bone tissue, the use of resorbable membranes, in&#xD;
      combination with autologous or heterologous particulate bone have been proposed. Expanded&#xD;
      polytetrafluoroethylene (e-PTFE) membranes are the most used non-resorbable membranes with&#xD;
      the longest published follow-up, considering them the gold standard in the reconstructions of&#xD;
      major horizontal bone defects. However, a second surgery is needed to remove them and they&#xD;
      may get exposed in the oral cavity and contaminate with possible infection and graft loss.&#xD;
      Conversely, the resorbable membranes most advantages are an ability to merge with the host&#xD;
      tissues, as well as a rapid resorption in case of exposure, thereby reducing the risk of&#xD;
      bacterial contamination. Resorbable membranes in combination with particulated anorganic&#xD;
      bovine bone (ABB) can be used for the augmentation of horizontally deficient ridges.&#xD;
      Particulated autogenous bone can be mixed with bone substitutes to add more osteogenic&#xD;
      factors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">November 12, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The patients will be randomly divided into 2 equal groups</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Each patient will be given a code by the researcher and the observers will be blind to which group this case belong.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Height and width of bone gained</measure>
    <time_frame>6 months</time_frame>
    <description>Height and width of bone gained in mm by CBCT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone area percentage</measure>
    <time_frame>6 months</time_frame>
    <description>Bone area percentage % by Histo-morphometric analysis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Bone Resorption Disorder</condition>
  <arm_group>
    <arm_group_label>GBR by xenograft</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients of both groups will be subjected to CBCT (diagnostic for upper arch).&#xD;
Intra operative procedures (for both groups) followed by CBCT will be taken for every patient.&#xD;
Local anesthesia will be given to the patient.&#xD;
Scrubbing and draping of the patient will be carried out in a standard fashion for intra oral procedures.&#xD;
Flap will be done.&#xD;
In the study group: bone decortication will be done using surgical round bur, anorganic bovine bone derived mineral will be packed then covered at the defected area by a native collagen membrane which will be stabilized by tacks.&#xD;
• The site will then be copiously irrigated with saline in preparation for closure.&#xD;
The flap will then be closed using interrupted 4/0 resorbable sutures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GBR by xenograft ,autogenous bone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention In the control group:first crestal incision then two vertical incisions by blade 15c,full thickness flap reflection, bone decortication will be done using surgical round bur, autogenous bone will be harvested by trephine bur ,mixed 1:1 with anorganic bovine bone derived mineral and packed at the defected area(atrophic maxilla) then covered by a native collagen membrane which will be stabilized by tacks.Then The flap will then be closed using interrupted 4/0 resorbable sutures.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>GBR by xenograft and autogenous bone</intervention_name>
    <description>Ridge augmentation by native collagen membrane and mix of anorganic bovine bone derived mineral with particulated autogenous bone chips (ratio 1:1).</description>
    <arm_group_label>GBR by xenograft</arm_group_label>
    <arm_group_label>GBR by xenograft ,autogenous bone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with atrophied anterior maxillary ridge area.&#xD;
&#xD;
          -  Age: 18 years and older.&#xD;
&#xD;
          -  Both sexes.&#xD;
&#xD;
          -  No intraoral soft and hard tissue pathology.&#xD;
&#xD;
          -  No systemic condition that contraindicate bone augmentation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Heavy smokers more than 20 cigarettes per day.(32)&#xD;
&#xD;
               -  Patients with systemic disease that may affect normal healing.&#xD;
&#xD;
               -  Psychiatric problems.&#xD;
&#xD;
               -  Disorders to bone augmentation are related to history of radiation therapy to the&#xD;
                  head and neck neoplasia.&#xD;
&#xD;
               -  Pregnant or nursing women.&#xD;
&#xD;
               -  Patients with uncontrolled diabetes mellitus, rheumatoid arthritis or&#xD;
                  osteoporosis.&#xD;
&#xD;
               -  Patient with previous history of radiotherapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hossam Elbaha</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hossam Elbaha, Master</last_name>
    <phone>+201277750002</phone>
    <email>hossam_elbaha@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>hossam Elbaha</last_name>
  </overall_contact_backup>
  <results_reference>
    <citation>Meloni SM, Jovanovic SA, Urban I, Canullo L, Pisano M, Tallarico M. Horizontal Ridge Augmentation using GBR with a Native Collagen Membrane and 1:1 Ratio of Particulated Xenograft and Autologous Bone: A 1-Year Prospective Clinical Study. Clin Implant Dent Relat Res. 2017 Feb;19(1):38-45. doi: 10.1111/cid.12429. Epub 2016 Jun 9.</citation>
    <PMID>27283920</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>November 3, 2018</study_first_submitted>
  <study_first_submitted_qc>November 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2018</study_first_posted>
  <last_update_submitted>August 28, 2019</last_update_submitted>
  <last_update_submitted_qc>August 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>hossam samir mohamed ahmed elbaha</investigator_full_name>
    <investigator_title>Principal Investigator(doctor)</investigator_title>
  </responsible_party>
  <keyword>GBR, autogenous bone, xenograft</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Resorption</mesh_term>
  </condition_browse>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>https://www.ncbi.nlm.nih.gov/pubmed/27283920</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

